Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2024 Aug 13;22(8):e3002380. doi: 10.1371/journal.pbio.3002380

The dynamics and longevity of circulating CD4+ memory T cells depend on cell age and not the chronological age of the host

M Elise Bullock 1,#, Thea Hogan 2,#, Cayman Williams 2,#, Sinead Morris 1, Maria Nowicka 1, Minahil Sharjeel 2, Christiaan van Dorp 1, Andrew J Yates 1,‡,*, Benedict Seddon 2,‡,*
Editor: Avinash Bhandoola3
PMCID: PMC11321570  PMID: 39137219

Abstract

Quantifying the kinetics with which memory T cell populations are generated and maintained is essential for identifying the determinants of the duration of immunity. The quality and persistence of circulating CD4 effector memory (TEM) and central memory (TCM) T cells in mice appear to shift with age, but it is unclear whether these changes are driven by the aging host environment, by cell age effects, or both. Here, we address these issues by combining DNA labelling methods, established fate-mapping systems, a novel reporter mouse strain, and mathematical models. Together, these allow us to quantify the dynamics of both young and established circulating memory CD4 T cell subsets, within both young and old mice. We show that that these cells and their descendents become more persistent the longer they reside within the TCM and TEM pools. This behaviour may limit memory CD4 T cell diversity by skewing TCR repertoires towards clones generated early in life, but may also compensate for functional defects in new memory cells generated in old age.


The quality and longevity of CD4+ effector and central memory T cells change with age in mice. This study shows that these cells have longer lifespans and become more quiescent when the organism ages, but these properties depend on the age of the cells and not on the age of the host environment.

Introduction

CD4 T cells can suppress pathogen growth directly and coordinate the activity of other immune cells [1,2]. Following exposure to antigen, heterogeneous populations of circulating memory CD4 T cells are established that enhance protection to subsequent exposures. In mice, these can be categorised broadly as central (TCM) or effector (TEM) memory. Canonically defined TCM have high expression of CD62L, which allow them to circulate between blood and secondary lymphoid organs, while CD4 TEM express low levels of CD62L and migrate to tissues and sites of inflammation. The lineage relationships between CD4 TCM, TEM, and other memory subsets remain unclear [3].

In mice, circulating memory CD4 T cells appear not to be intrinsically long-lived on average but are lost through death or onward differentiation on timescales of days to weeks [49]. However, compensatory self-renewal can act to sustain memory T cell clones, defined as populations sharing a given T cell receptor (TCR), for much longer than the life span of their constituent cells [10]. To understand in detail how the size of memory T cell populations change with time since exposure to a pathogen, we therefore need to be able to quantify their rates of de novo production, division, and loss; any heterogeneity in the rates of these processes; how kinetically distinct subsets are related; and how these kinetics might change with host and/or cell age.

Much of our knowledge of memory CD4 T cell dynamics derives from studies of laboratory mice housed in specific pathogen-free conditions, which have not experienced overt infections, but nevertheless have abundant memory phenotype (MP) CD4 T cells [1113]. These populations contain both rapidly dividing and more quiescent populations [4,1417], a stratification that holds within the TCM and TEM subsets [5]. MP T cells are established soon after birth and attain broadly stable numbers determined in part by the cleanliness of their housing conditions [18]. After the first few weeks of life, however, both CD4 TCM and CD4 TEM are continuously replaced at a rates of a few percent of the population size per day [5], independent of their housing conditions [18]. MP CD4 T cells are therefore likely specific for an array of commensals, self, or ubiquitous environmental antigens and may comprise subpopulations at different stages of maturation or developmental end points. Dissecting their dynamics in detail may then shed light on the life histories of conventional memory cells induced by infection.

A widely used approach to studying lymphocyte population dynamics is DNA labelling, in which an identifiable agent such as bromodeoxyuridine (BrdU) or deuterium is taken up during cell division. By measuring the frequency of cells within a population that contain the label during and following its administration, one can use mathematical models to extract rates of production and turnover (loss). Without allowing for the possibility variation in these rates within a population, their average estimates may be unreliable [19,20]. Explicit treatment of such “kinetic heterogeneity” can yield estimates of average production and loss rates that are interpretable and independent of the labelling period, although the number of distinct subsets and the lineage relationships between them are difficult to resolve [4,5,18,21,22]. Further, models of labelling dynamics usually conflate the processes of influx of new cells and self-renewal of existing ones into a single rate of cell production. Distinguishing these processes is particularly important in the context of memory, because their relative contributions determine the persistence of clones within a population; for a population at equilibrium, clones are diluted by influx but sustained by self-renewal.

To address these uncertainties, one can combine DNA labelling with information from other systems to validate predictions or constrain the choice of models. One approach is to obtain an independent estimate of any constitutive rate of flow into a population by following its replacement by labelled precursors. In a series of studies, we established a mouse model that yields the rates of replacement of all peripheral lymphocyte subsets at steady state [5,18,2328]. In this system, illustrated in Fig 1A, low doses of the transplant conditioning drug busulfan are administered to specifically deplete haematopoietic stem cells (HSCs) in adult mice, while leaving peripheral lymphocyte compartments undisturbed. Shortly afterward, the treated mice receive T and B cell–depleted bone marrow from congenic donors, to reconstitute the HSC niche. Donor fractions of 70% to 90% are established rapidly among HSC, which are stable long term [23]. Within 6 weeks of transplant, the fraction of cells that are donor-derived (the chimerism) equilibrates at similar levels at all stages of thymic development and at the transitional stage of B cell development, indicating that turnover of all these populations is complete within this time frame [23]. Donor-derived cells proceed to gradually replace host-derived cells in all peripheral lymphocyte compartments over timescales of weeks to months, first within naive populations and then more gradually within antigen-experienced subsets [5]. Importantly, total cell numbers within each subset remained indistinguishable from untreated controls at all timepoints [5], indicating that cells originating from the sex- and age-matched donor and host HSC behaved identically. By using mathematical models to describe the timecourse of replacement within a particular population, one can obtain a direct estimate of the rate of influx of new cells, which can be fed directly into models of DNA labelling [5]. A conceptually similar approach to measuring influx is to use division-linked labelling to explicitly model the kinetics of label in both the population of interest and its precursor. This method is particularly useful when labelling is inefficient, because labelling among precursors is not saturated and is time-varying. Their influx then leaves an informative imprint on any labelling within the target population itself, allowing the rate of ingress of new cells to be inferred [29].

Fig 1. Busulfan chimeric mice, experimental design, and gating strategies.

Fig 1

(A) Schematic of the busulfan chimeric mouse system, adapted from [32]. (B) Design of the BrdU/Ki67 labelling assay, studying 2 cohorts at different times post BMT. (C) Chimeric mice were fed BrdU for 21 days. Mice were analysed at different times during feeding and across 14 days following its cessation. Here, we show representative timecourses obtained from donor-derived CD4 TCM and TEM, showing patterns of Ki67/BrdU expression during and after BrdU feeding. See Methods and Fig A of S1 File for details and gating strategies.

Another means of boosting the resolving power of DNA labelling assays is to use concurrent measurements of Ki67, a nuclear protein expressed during mitosis and for a few days afterwards [23,30,31]. A cell’s BrdU content and Ki67 expression then report its historical and recent division activity, respectively. This approach was used to study MP CD4 T cell dynamics [5] and rule out a model of “temporal heterogeneity,” in which CD4 TCM and TEM cells each comprise populations of cells that divide at a uniform rate, but that a cell’s risk of loss varied with its expression of Ki67. The BrdU/Ki67 approach instead supported a model in which CD4 TEM and TCM each comprise at least 2 kinetically distinct (“fast” and “slow”) subpopulations, consistent with other studies [4,16,17]. These subpopulations were assumed to form independent lineages that branch from a common precursor [5], but a subsequent study using the busulfan chimera system alone found support for an alternative model in which memory cells progress from fast to slow behaviour [18]. The topologies of the kinetic substructures of CD4 TCM and TEM therefore remain uncertain.

Here, we aimed to characterise the dynamics CD4 TCM and TEM in full, by combining these two approaches—performing BrdU/Ki67 labelling within busulfan chimeric mice directly. Our reasoning was three-fold. First, if one defines a memory cell’s age as the time since it or its ancestor entered the memory pool, the average age of donor (newly recruited) clones will be lower than that of the host-derived clones that they are replacing. By stratifying the BrdU/Ki67 analyses by donor and host cells, one can therefore quantify any changes in the kinetics of memory T cell clones with their age. Second, by performing the labelling experiments in young and aged cohorts of mice, one can simultaneously observe any changes in dynamics due to the mouse’s chronological age. Third, this combined approach could allow us to define the relationship between fast and slow memory CD4 T subsets and identify the immediate precursors of CD4 TCM and TEM.

Results

Performing DNA labelling assays in busulfan chimeric mice

We studied 2 age classes of mice (Fig 1B). In one cohort, mice underwent busulfan treatment and bone marrow transplant (BMT) aged between 58 and 116 days, and BrdU/Ki67 labelling was performed 56 to 91 days later (at ages 150 to 175 days). For brevity, we refer to these as “young” mice. An “old” cohort underwent treatment and BMT at similar ages but with labelling performed between 246 and 260 days later (at ages 304 to 341 days). BrdU was administered by intraperitoneal injection and subsequently in drinking water for up to 21 days. Mice were killed at a range of time points within this period or up to 14 days after BrdU administration stopped. CD4 TCM and TEM were recovered from lymph nodes, enumerated, and stratified by their BrdU content and Ki67 expression (Fig 1C and Fig A of S1 File).

The proliferative activity of CD4 TCM and TEM declines as they age

We first analysed the bulk properties of CD4 MP T cells within the two cohorts. The total numbers of CD4 TCM and TEM recovered from lymph nodes increased slightly with age (Fig 2A). Proliferative activity, measured by the proportion of cells expressing Ki67 (Fig 2B), fell slightly with age among CD4 TCM (median Ki67high fraction = 0.44 in young cohort, 0.36 in older cohort, p = 0.02) but not significantly for TEM (median Ki67high fraction = 0.20 in both age groups, p = 0.48).

Fig 2. Busulfan chimeric mice reveal shifts in memory CD4 T cell dynamics with both mouse age and cell age.

Fig 2

(A, B) Numbers and Ki67 expression levels of CD4 TCM and TEM recovered from lymph nodes in young and old cohort (Mann–Whitney tests). (C, D) Numbers and Ki67 expression levels of CD4 TCM and TEM in young and old mice, stratified by average cell age (host and donor; Wilcoxon tests). The data underlying this figure can be found in S1 Data. ** p < 10−3; *** p < 10−4; **** p < 10−5.

Consistent with reports of the production of new MP CD4 T cells throughout life [5,18], and the progressive enrichment of all T cell subsets in donor-derived cells after BMT, the composition of both memory subsets shifted towards donor cells in older mice (Fig 2C). This shift was more marked for TCM (p < 10−4) but was also significant for TEM (p < 10−3). Strikingly, in the younger cohort, donor TCM and TEM both expressed Ki67 at substantially higher frequencies than their host counterparts (Fig 2D; p < 10−8 both cases). These differences diminished with time post BMT but remained significant in the older cohort (p < 10−3 for both TCM and TEM).

These patterns of donor/host cell differences indicate that the average levels of proliferation within cohorts of CD4 TCM and TEM decline with the time since they or their ancestors entered the population. This effect is most apparent among TCM but still appreciable for TEM.

Modelling BrdU/Ki67 labelling kinetics in busulfan chimeric mice

To find a mechanistic explanation of these patterns, we then analysed the BrdU/Ki67 timecourses derived from the young and old mice. As described in Methods, and illustrated in Fig 1B, in each age cohort, we followed the uptake and loss of BrdU within CD4 TCM and TEM, stratified by host and donor cells and by Ki67 expression, during 21-day pulse and 14-day chase periods. This strategy allowed us to isolate the dynamics of new and old memory cells within young and old mice.

We attempted to describe these data using three classes of mathematical model, shown schematically in Fig 3A. We employed two versions of a kinetic heterogeneity model: branched, in which newly generated TCM and TEM both immediately bifurcate into independent subpopulations (A and B) with distinct rates of division and death [5], and linear, in which cells enter memory with phenotype A and mature into a kinetically distinct phenotype B [18] (Fig 3A, models (ii) and (iii)). We also explored a “burst” model, describing a form of “temporal heterogeneity” [22], in which each memory subset (TCM/TEM, host/donor) comprises quiescent cells of type A, which are relatively long-lived and when triggered to divide enter a more dynamic state B, undergoing faster divisions with a reduced life span. These cells return to the quiescent state at some unknown rate. The burst model is a generalisation of the temporal heterogeneity model we rejected previously [5], in which Ki67high cells, which are actively dividing or divided recently, are lost at a different rate to that of more quiescent Ki67low cells. The burst model is also conceptually similar to that explored in [33], in which a cell’s risk of death changes with the time since its last division. In all the models, new cells entering memory are assumed to be Ki67high, reflecting the assumption that they have recently undergone clonal expansion.

Fig 3. Modelling BrdU/Ki67 timecourses.

Fig 3

(A) Models of heterogeneity in cellular dynamics within a memory subset. Adapted from [32]. (B) Schematic of the core component of the ODE model used to describe the uptake of BrdU and the dynamic of Ki67 expression. (C, D) Fitted kinetics of BrdU uptake and loss in CD4 TCM and TEM, in the young (C) and older (D) cohorts of mice, using the branched model. The left column shows the frequency of BrdU-positive cells within donor and host cells. Centre and left columns show the proportion of BrdU-positive cells within Ki67-positive and Ki67-negative cells, respectively. There were 2 mice per time point for both donor and host throughout; in some panels, these points are very close and overlaid. The data underlying this figure can be found in S1 Data.

We encoded these models with systems of ordinary differential equations. The core structure, which describes the flows between BrdU± and Ki67high/low populations as they divide and die during the labelling period, is illustrated in Fig 3B. A detailed description of the formulation of the models is in Text A of S1 File.

Within both cohorts of mice, the total numbers of host and donor CD4 TCM and TEM cells, and the frequencies of Ki67high cells within each, were approximately constant over the course of the labelling assays (Fig B of S1 File). We therefore made the simplifying assumption that both donor and host memory populations were in quasi-equilibrium, with any changes in their numbers or dynamics occurring over timescales much longer than the 35-day labelling experiment. We took a Bayesian approach to estimating model parameters and performing model selection, using Python and Stan, which is detailed in Text B of S1 File. The code and data needed to reproduce our analyses and figures can be found at github.com/elisebullock/PLOS2024.

Multiple models of memory CD4 T cell dynamics can explain BrdU/Ki67 labelling kinetics

The BrdU labelling data are summarised in Fig 3C and 3D, shown as the accumulation and loss of BrdU within each population as a whole (left hand panels) and within Ki67high and Ki67low cells (centre and right panels). In the young cohort (Fig 3C), the labelling kinetics of more established (host) and more recently generated (donor) CD4 TCM and TEM were quite distinct, with slower BrdU uptake within host-derived populations. In addition, heterogeneity was apparent in all labelling timecourses. For a kinetically heterogeneous population, the slope of this curve declines as the faster-dividing populations become saturated with label, and the majority of new uptake occurs within cells that divide more slowly. Such behaviour was apparent, consistent with the known variation in rates of division and/or loss within both TCM and TEM. In the older cohort (Fig 3D), BrdU uptake was slower, differences between donor and host kinetics were less apparent, and the labelling kinetics of host-derived cells were similar to those in the younger cohort.

Intuitively, the initial rate of increase of the BrdU-labelled fraction in a population will depend both on the mean division rate of the population and the efficiency of BrdU incorporation per division [34]. This efficiency, which we denote ϵ, is unknown, and this uncertainty can confound the estimation of other parameters [34,35]. In this regard, the timecourses of the proportion of Ki67high cells that are BrdU-positive (Fig 3C and 3D, centre panels) are highly informative. Any deviation from a rapid increase to 100% places bounds on ϵ, and as we see below, the posterior distributions of this parameter were narrow. Similarly, the kinetics of the BrdU-positive fraction within Ki67low cells reflect the lifetime of Ki67 expression—we expect this lifetime to be the delay before the first BrdU-positive Ki67low cells appear, which is clearly apparent in the data (Fig 3C and 3D, right hand panels) and was again tightly constrained in the model fitting.

To test whether all the parameters of the models illustrated in Fig 3A were identifiable, we fitted each to simulated BrdU/Ki67 labelling timecourses that were generated by the model with added noise. For all models, the estimated total rate of influx of new cells into memory was strongly correlated with the net loss rate of the direct descendant(s) of the source, indicating that these parameters are not separately identifiable. To resolve this, we obtained independent estimates of the rates of influx by modelling the slow accumulation of donor CD4 TCM and TEM within cohorts of busulfan chimeric mice over long timescales (Text C and Fig C of S1 File). The posterior distributions of these estimates (summarised in Table A of S1 File) yielded strong priors on the influx rates for the subsequent analyses.

We fitted the branched, linear, and burst models to each of the 8 timecourses—CD4 TCM and TEM separately for donor and host, in both young and old cohorts. All three models yielded excellent fits to the data; surprisingly, these fits were statistically and visually indistinguishable (Table B of S1 File). (Confirming our earlier conclusions [5], the simple temporal heterogeneity model in which Ki67high and Ki67low cells had different death and division rates performed poorly (Fig D of S1 File), and we do not consider it further here.) However, the parameters estimated for the linear and bursting model exhibited some colinearity (Fig E of S1 File, panels A and B), so we proceed by describing the branched model, whose parameters were most clearly identifiable (Fig E of S1 File, panel C). The fits of the branched model are overlaid in Fig 3C. The posterior distributions of its parameters are shown in Fig 4 and summarised in Table C of S1 File. Corresponding results for the linear and burst models are shown in Figs F and H and Table D of S1 File and Figs G and I and Table E of S1 File, respectively. Importantly, however, the conclusions we draw from here onwards are supported by all three models.

Fig 4.

Fig 4

Posterior distributions of parameters derived from the branched model of the kinetics of CD4 TCM (A) and TEM (B), in the young and old cohorts of mice. Grey violin plots show differences in parameters (host/donor, and young/old). Points and bars show MAP estimates and 95% credible intervals, respectively. The data underlying this figure can be found in S1 Data.

Clonal age effects explain changes in CD4 TCM and TEM dynamics with mouse age

For both CD4 TCM and TEM, the branched model fits indicated that in both young and older mice, cells that enter the faster subpopulation from the precursor pool divided and were lost over timescales of a few days. In contrast, slow cells divided rarely (mean interdivision times of 100 to 200 days) and had life spans of 60 to 100 days (Fig 4). While the differences in these two subpopulations are clear, these division and loss rate estimates are rather broad because they still exhibited some colinearity (Fig E of S1 File, panel C). We return to the issue of estimating memory cell lifetimes below. Quantities that were better defined, and perhaps immunologically more relevant, were the balance of loss (at rate δ) and self-renewal (at rate α) for each subpopulation. This net loss rate, λ = δα, defines the loss of a population in bulk, rather than the turnover of its constituent cells. For example, if the rate at which cells are lost is is balanced exactly by their rate of self-renewal, λ = 0 and the population is sustained indefinitely (that is, it is in dynamic equilibrium). In the context of our study, the time taken for a cohort of cells entering a population to halve in size is then (ln 2)/λ. We estimated this quantity for the TCM and TEM populations in bulk, but this half-life is particularly relevant because it simultaneously defines the persistence of a TCR clone. To emphasise this point, we refer to (ln 2)/λ as a “clonal” half-life, even though we do not track individual clonotypes in our study. The similarity in the rates of division and loss of fast cells implied that fast CD4 TCM and TEM populations were remarkably persistent, with clonal half lives of between 35 and 70 days, and TEM slightly less persistent than TCM. In contrast, the slower memory cells self-renewed rarely, so their clonal half-lives (70 to 140 days) were governed largely by the cell life span and were similar for TCM and TEM.

Going beyond these broad characterisations, we wanted to identify the basis of the observed host/donor differences and any changes in memory dynamics with cell age or mouse age. In particular, in young mice, for both CD4 TCM and TEM, we inferred that the higher expression of Ki67 within donor cells was due to a greater prevalence of fast cells, compared to host (Fig 4). In Text D of S1 File, we show that these differences arise because slow, host-derived memory cells were more persistent than their younger donor counterparts, while fast cells behaved similarly, irrespective of cell age (host/donor status) or mouse age. We also found that this increase in the persistence of more quiescent memory clones with their age derived from increased cell life span, rather than an increase in rates of self renewal. These conclusions held for all three (branched, linear, and burst) models.

We expected the age structure of host-derived CD4 TCM and TEM to change between young and old cohorts to a lesser extent than that of the donor cells. Therefore, any changes linked directly to mouse age ought to be more manifest among host cells. However, we saw no shifts in host cell kinetics between the age cohorts, reflected in the similarity of their BrdU/Ki67 labelling curves (Fig 3, panels C and D). Therefore, we could not detect any effects of mouse age on the dynamics of circulating memory CD4 T cells. We can also conclude that increases in the survival capacities of slow CD4 TCM and TEM with cell age must saturate over a timescale of weeks; if they did not, we would expect to see a decline in the loss rates of host-derived memory cells in older mice.

In summary, the stark differences in donor and host kinetics in younger mice are readouts of the effects of cell age, defined as the time since a cell or its ancestor entered the CD4 TCM or TEM population. As they age, slow CD4 TCM and TEM clones become more persistent, shifting the population as a whole to a more quiescent state and explaining the decline in Ki67 within these subsets as mice age. The convergent dynamics of host and donor cells in older mice reflect a convergence in their cell age profiles.

Comparing memory CD4 T cell life spans to previous estimates

The other DNA labelling studies we are aware of that measured or inferred memory CD4 T cell life spans in mice reported the population average and did not distinguish TCM and TEM [4,8,34]. For comparison, we used 3 independent methods of deriving the corresponding mean life span from our data.

Westera and colleagues [4], using heavy water labelling, showed that it is necessary to allow for multiple subpopulations with different rates of turnover to obtain parameter estimates that are independent of the labelling period. They were not able to resolve the number of subpopulations or their rates of turnover individually but established a robust estimate of the mean life span of 15 days (range 11 to 15) in adult mice. Baliu-Pique and colleagues [8] employed the same approach to derive a life span of 8 days (95% CI 5 to 15). To obtain an analogous estimate, we used the model parameters to calculate the average loss rate of fast and slow cells among both donor and host, each weighted by their population sizes (Text E of S1 File). Fig 5A shows the posterior distributions of the life spans of TCM and TEM separately, with point estimates of roughly 8 and 21 days, respectively, and with little change with mouse age. Notably, our confidence in these quantities is greater than our confidence in the life spans of fast and slow populations themselves (Fig 4). To calculate a population-average life span, we account for the lower prevalence of TCM relative to TEM (Fig 5B). The resulting weighted estimates were 18 days (95% CrI 16 to 21) for younger mice, and 20 days (18 to 22) in the older cohort (Fig 5C).

Fig 5. Estimates of the mean life span of circulating memory CD4 T cells in the 2 age cohorts of mice.

Fig 5

(A) Expected life spans of CD4 TCM and TEM in young and old mice, each averaged over fast and slow subpopulations (see Text E of S1 File). (B) Relative abundance of lymph node-derived CD4 TCM and TEM, by age. (C) Estimated mean life spans of memory CD4 T cells, averaging over TCM and TEM, in the young and old cohorts. Violin plots show the distributions of the life spans over the joint posterior distribution of all model parameters; also indicated are the median and the 2.5 and 97.5 percentiles. The data underlying this figure can be found in S1 Data.

We obtained estimates of the mean life span of memory CD4 T cells in 2 other ways. Both rely on estimating the total rate of production, which at steady state is balanced by the average loss rate, which is the inverse of the mean life span. One method is to use the initial upslope of the BrdU labelling curve, which reflects the total rate of production of new memory cells through division and influx. One can show that the mean life span is approximately 2ϵ/p, where ϵ is the efficiency of BrdU uptake and p is the early rate of increase of the BrdU+ fraction (Text F of S1 File). In the young cohort, these rates were roughly 0.08/day and 0.04/day for TCM and TEM, respectively; in older mice, 0.1 and 0.05. Accounting again for the TCM and TEM abundances (Fig 5B), we obtain rough point estimates of the life span of 25 days in the younger cohort and 27 days in the older mice. A similar calculation was employed by De Boer and Perelson [34], who drew on BrdU labelling data from Younes and colleagues [17] to obtain a mean life span of between 14 and 22 days (Text F of S1 File).

The second method is to utilise Ki67 expression, which again reflects the production of cells through both influx and cell division. If the fraction of cells expressing Ki67 is k, and Ki67 is expressed for T days after division, one can show that the mean life span is approximately −T/ ln(1 −k/2) (Text F of S1 File). The frequencies of Ki67 expression within CD4 TCM and TEM were roughly 0.4 ± 0.1 and 0.2 ± 0.1, respectively, and were similar in young and old mice (Fig 1B); using these values weighted by the abundances of TCM and TEM (Fig 5B, EM/CM ≃ 7.5 ± 2), with our estimated T = 3.1d gives a mean life span of approximately 25 days, although with some uncertainty (conservative range 15 to 70d).

In summary, we find robust estimates of the average life span of memory CD4 T cells that increase slightly with mouse age and are in line with estimates from other studies.

Using patterns of chimerism to identify the precursors of CD4 TCM and TEM

These models of CD4 TCM and TEM dynamics made no assumptions about the identity of their precursors—they only assumed that the rates of influx of host and donor precursors into each subset were constant over the course of the labelling assay and that new memory cells expressed Ki67 at high levels. Because the donor/host composition of this influx presumably reflects the chimerism of the precursor population, we reasoned that by comparing the chimerism of the flows into CD4 TCM and TEM to that of other populations, we could infer the lineage relationships between naive and circulating memory CD4 T cell subsets.

Fig 6 shows these chimerism estimates. Our analysis of the rate of accumulation of donor cells within CD4 TCM and TEM in busulfan chimeric mice (Text C and Fig C of S1 File) yielded the chimerism of the flows into these subsets, shown in green on the left of each panel in Fig 6. We also used the posterior distributions of parameters from the fitted models to estimate the chimerism within fast and slow subsets (split colour violin plots, shown for branched and linear models; those derived from the burst model were very similar, and for clarity are not shown). The points represent experimental observations.

Fig 6. Inferred and measured values of the chimerism (donor cell fraction) within thymic and peripheral T cell subpopulations.

Fig 6

Left-hand (green) violin plots indicate the chimerism of the constitutive influxes into CD4 TCM and TEM estimated using Eq 1 of Text C of S1 File, fd. Split-colour violin plots indicate the posterior distributions of the chimerism within fast and slow subsets of CD4 TCM and TEM; red and lilac indicate the linear and branched model predictions, respectively. Points represent experimentally observed donor fractions within early-stage double-positive thymocytes (DP1), naive T cells, and CD4 TCM and TEM derived from lymph nodes. The data underlying this figure can be found in S1 Data.

As expected, chimerism in different cell populations showed considerably more variation in the young cohort, which had undergone BMT relatively recently, than in the older cohort in which donor/host ratios throughout the peripheral T compartments had had more time to equilibrate. We therefore focused on the younger cohort to establish potential differentiation pathways.

One source of new memory might be antigen-specific recent thymic emigrants (RTEs), whose chimerism would be expected to be similar to that of early-stage double positive thymocytes (DP1). However, the observed chimerism of DP1 cells (Fig 6) was much higher than the inferred chimerism of the TCM and TEM precursors, so our analyses do not support RTE as the dominant source of new CD4 MP T cells. Instead, the chimerism of TCM precursors aligned well with that observed within bulk naive CD4 T cells, and the chimerism of the TEM precursors aligned with that of TCM. This pattern clearly suggests a naive → TCM → TEM developmental pathway for CD4 MP T cells, consistent with the order in which donor-derived cells appear within these subsets in busulfan chimeras (Fig C of S1 File). It was also clear that the estimated chimerism within slow memory cells was too low for them to be an exclusive source for any other population, consistent with their being predominantly a terminal differentiation stage in memory T cell development. Instead, our observations are consistent with a model of development in which new CD4 TEM derive predominantly from more rapidly dividing CD4 TCM.

Age-dependent survival rates explain shortfalls in replacement within TCM and TEM

In older busulfan chimeric mice, the replacement curves for CD4 TCM and TEM saturated at donor fractions of approximately 0.7 and 0.6, respectively (Fig 6 and Fig C of S1 File), lower than that of naive CD4 T cells (Fig 6). Given that the average life spans of CD4 TCM and TEM are a few weeks, it is then perhaps puzzling that the donor fractions within all three compartments do not equalise at late times after BMT. Our analysis suggests that these shortfalls are an effect of cell age–dependent survival. The mean life span is a rather crude measure of memory turnover, as life spans are significantly right-skewed; in addition, slower cells increase their life expectancies as they age. This increase will lead to a first-in, last-out effect in which donor T cell clones will always be at a survival disadvantage, on average, relative to their older host counterparts. This effect naturally leads to a shortfall in the donor fraction within each memory subset relative to its precursor (putatively, TCM relative to naive; and TEM relative to TCM). As the mice age and the donor and host cell age distributions converge, this shortfall decreases but still remains (Fig 6).

Validations of model assumptions and fits in other systems

Previously, we showed that the total numbers of memory CD4 T cells are indistinguishable in busulfan chimeric mice and wild-type (WT) controls [5]. However, there remains the possibility that the observed differences in the behaviour of host and donor memory CD4 T cells in busulfan chimeras derives in some way from the impact of drug treatment and HSC transplant, rather than simply from their different age profiles. We therefore sought to use 2 independent mouse reporter systems to validate the structure of our models, and the results of the model fitting.

First, we used an adoptive transfer approach to test the assumptions underlying our models. Ki67mCherry-CreERT Rosa26RcagYFP mice express a Ki67-mCherry fusion protein and inducible CreERT from the Mki67 locus [26] together with a Rosa26RcagYFP Cre reporter construct (Materials and methods). Treatment of donor mice with tamoxifen therefore induces YFP in cells expressing Ki67. Three days following treatment, we isolated either bulk CD4+ conventional T cells or purified CD4+ TEM from the lymph nodes of these reporter mice and adoptively transferred them into WT CD45.1 congenic hosts (Fig J of S1 File, panel A). As expected, Ki67 levels within YFP+ cells were higher than among YFP cells (Fig 7A and Fig J of S1 File, panel B); having divided in the days prior to transfer, the YFP+ cells were enriched for faster-dividing populations. We then assessed Ki67 expression among the transferred cells 7 days after transfer (Fig 7B and Fig J of S1 File, panel C). We made two key observations. First, we found that Ki67 levels within donor-derived CD4 TEM declined when they were transferred alone but were preserved following the transfer of CD4 T cells in bulk. This result is consistent with our basic assumption of continued production of new, Ki67high CD4 TEM from a precursor that is within circulating CD4 T cells. Second, we observed that Ki67 levels among YFP+ cells also fell and converged with that of YFPcells. The decline is consistent with the assumption of kinetic heterogeneity; if memory cells divided and died at a constant rate, we would expect the level of Ki67 within the YFP+ cells to be preserved. Notably, the decline and convergence of Ki67 levels within YFP+ and YFPcells is predicted by all three models (Text G of S1 File).

Fig 7. Validation of the structure and predictions of the models of memory CD4 T cell dynamics.

Fig 7

(A) CD4 TEM after tamoxifen treatment, pretransfer, with Ki67 expression stratified by YFP expression. (B) Proportions of cells in bulk, YFP+ and YFPCD4 TEM expressing Ki67 at days 0 and 7 after transfer. (C) Empirical description (fitted green curve) of the observed timecourse of the frequency of mTom+ cells within the naive CD4 T cell pool, after tamoxifen treatment of CD4 reporter mice. Dilution is driven by the influx of unlabelled cells from the thymus. (D) Observed and predicted frequencies of mTom+ cells within the CD4 TCM and TEM following tamoxifen treatment. Shaded regions span the 2.5 and 97.5 percentiles of the distribution of predicted trajectories, generated by sampling 1,000 sets of parameters from their joint posterior distribution. The data underlying this figure can be found in S1 Data.

Second, we used CD4CreERT Rosa26RmTom mice to directly test the predictions of our fitted models. In this system, the Cre reporter is constructed such that cells expressing CD4 during tamoxifen treatment permanently and heritably express the fluorescent reporter mTomato (mTom). In a closed self-renewing population, the frequency of cells expressing mTom will therefore remain constant. Any decline in this frequency therefore reflects the influx of unlabelled precursors. We tamoxifen-treated a cohort of CD4 reporter mice that were age-matched to our younger cohort of busulfan chimeras and followed them for approximately 18 weeks (Fig J of S1 File, panel D). We described the timecourse of the mTom+ fraction within naive CD4 T cells empirically (Fig 7C, green curve). We then used the parameters of our fitted models to predict the timecourses of mTom+ frequencies within CD4 TCM and TEM (Fig 7D; see Text H of S1 File for modelling details). The predictions of all three models were identical, and for both TCM and TEM agreed well with the data, with better visual support for TCM as a precursor to TEM (Fig 7D, rightmost panel). This agreement demonstrates that the kinetics of memory CD4 T cells derived from busulfan chimeric mice are indistinguishable from those in mice that have not undergone HSC depletion and replacement, and so supports our assertion that differences in behaviour of host and donor T cells derive only from their different age distributions and not any ontogenic differences. The simulations also lend support to a dominant CD4 TCM → TEM differentiation pathway.

Discussion

Our key result is that the longer a cohort of CD4 TCM or TEM persists in memory, the greater the expected life spans of its constituent cells. A consequence of this effect is that the average loss rate of antigen-specific memory CD4 populations decreases as they age. This behaviour mirrors that of naive CD4 and CD8 T cells that we and others have identified in both mice [27,28,36] and humans [37], suggesting it is an intrinsic property of T cells.

This dynamic will lead to the accumulation of older memory CD4 T cells. In contrast, a recent study argued that an increase in cell mortality with cell age may act to preserve the TCR diversity of memory populations as an individual ages, and, hence, be beneficial [38]. In the latter study, cell aging was directly associated with cell divisions, whereas here we defined age to be a heritable clock that measures the time since a cell’s ancestor entered the memory pool. These two measures of age are positively correlated, but any division-aging effects would manifest more strongly among fast memory cells than among slow. Indeed, we found that slow memory cells self-renew rarely. It has also been shown that memory cells deriving from aged naive T cells may be functionally impaired [3941]. It is therefore unclear what cell age effects are optimal for the long-term preservation of functional memory repertoires.

The mechanistic basis of any change in survival with cell age is unclear. Memory T cells may undergo maturation that increases their expected time-to-die as they age, such as the gradual acquisition of senescence markers. An alternative is a simple selection effect in which every cohort of new memory T cells is heterogeneous in its survival capacity, and more persistent clones are selected for over time. Another possibility is that memory cells experience slow changes in their microenvironments; for example, progressive alterations in receptor expression that might alter their circulation patterns and influence the availability of survival signals. This shift in trafficking patterns would then be a proxy for cell aging. To explore this idea, one would need to perform histology to study the spatial distributions of donor- and host-derived memory cells in the younger cohorts of mice, where the average ages of the two populations are most different.

The development and long-term maintenance of memory CD4 T cell subsets has been studied less extensively than those of CD8 T cells, but the dynamics of the latter have some key similarities with the results we describe here and may help to resolve some of the ambiguities in our analyses. A study involving deuterium labelling of yellow fever virus (YFV)-specific CD8 T cells in humans [42] demonstrated a progressive shift to quiescence over months to years, with surviving memory T cells being very long lived and dividing rarely. Zarnitsyna and colleagues [43] explored a variety of mathematical models to quantify this kinetic and found the strongest support for rates of both division and death that decline with time and result in a power-law decrease in memory cell numbers. Akondy and colleagues [42] found that cells persisting long term were deuterium-rich, indicating that they were derived from populations that divided extensively in the days to weeks following challenge. This kinetic gives support to the linear or burst models of memory, rather than the branched model in which the more persistent cells are quiescent from the moment they enter the memory population.

MP CD4 T cells divide more rapidly on average than conventional antigen-specific memory cells [1517]. Younes and colleagues [17] argued that MP CD4 T cells comprise a proliferative subset and a slower population with the properties of conventional memory. This distinction was motivated by the observation that bulk and LCMV-specific memory CD4 T cells, identified with tetramer staining 15 days after LCMV challenge, were phenotypically similar but had Ki67 expression levels of 25% to 40% and 5%, respectively. Bulk memory is presumably enriched for MP cells, and indeed, the frequencies of Ki67 expressing cells they observed among the tetramer-negative population are consistent with the roughly 30% weighted average among CD4 TCM and TEM in our analyses (Fig 2B).

There have been conflicting reports regarding the signals required for the generation and maintenance of fast MP CD4 T cells. Younes and colleagues argued that they are driven by cytokines, based on the lack of an effect of an MHC class II-blocking antibody and a modest reduction in proliferation under IL-7R blockade [17]. Their results contrasted with reports that rapidly dividing MP CD4 T cells depend on interactions with MHC class II and require proximal TCR signalling kinases to sustain proliferation [16,44] and have reduced dependence on IL-7 compared to antigen-specific CD4 memory [15]. However, later studies from the same lab as Younes and colleagues identified the importance of costimulation signals from CD28 for the proliferation of fast cells even though division was not affected by MHC class II blockade [12]. The same study highlighted the importance of TCR and CD28 costimulation signals for the generation of MP CD4 T cells from naive precursors. These observations can be reconciled if the generation and maintenance of MP CD4 T cells rely on CD28 and TCR interactions but vary in the threshold of TCR signalling required and if there is redundancy with CD28 signals. In addition, interpretation of MHC class II blockade experiments is heavily dependent upon whether antibody blockade is considered absolute, or, as is more likely the case, only partial. If the latter is true, the reduction in availability of MHC class II ligands may be sufficient to block priming events but insufficient to halt self-renewal of existing memory.

Given the involvement of TCR signals in the production of new MP CD4 T cells, the difference in average levels of proliferation within bulk MP CD4 T cells and antigen-specific memory observed by Younes and colleagues [17] might be explained quite simply by the fact that MP T cells are continually produced in response to chronic stimuli with self or commensal antigens, while LCMV-specific memory will become less proliferative with time post-challenge as the acute infection resolves. The transfer experiment we described here supports this interpretation; CD4 TEM in isolation lost Ki67 expression, whereas when CD4 T cells were transferred in bulk, Ki67 levels on CD4 TEM were maintained, presumably because their precursors were also present and continued to be stimulated. Similar reasoning might explain the report by Choo and colleagues that memory CD8 T cells specific for epitopes of LCMV divide at the same rate as memory CD8 T cells in bulk [45]. They established this equivalence by labelling each population with CFSE, transferring them into congenic recipient mice and comparing their CFSE dilution profiles; by doing so, the source of any new, more proliferative MP CD8 cells was presumably removed or diminished, and the remaining polyclonal populations divided at the same slow rate as the LCMV-specific cells. In summary, MP T cells, rather than being distinct from conventional antigen-specific memory cells, may in fact represent a cross-section of the entire process of memory generation and maintenance.

The binary characterisation of fast and slow that we model here may be a simple representation of a more heterogeneous system. Younes and colleagues [17] saw a 4-fold disparity in Ki67 expression between tetramer-positive (LCMV-specific) and tetramer-negative (MP) CD4 T cells 15 days post-challenge, indicating that fast LCMV-specific memory persisted for only a few days. This transience contrasts to the more extended residence times of fast populations, at the clonal level, that we inferred here. The MP populations we studied likely respond to a variety of commensal or environmental antigens. CD4 TCM and TEM may therefore exhibit variability in their persistence times in a clone-specific way, perhaps depending on antigenic burden, TCR specificity, or their T helper phenotype [46].

By augmenting measurements of BrdU content with Ki67 expression, here and in a previous study, we could reject a model of “temporal heterogeneity” in which cells expressing Ki67 are both more likely to divide again and at increased risk of loss or onward differentiation. However, the burst model we considered here is a generalisation in which the duration of this more “risky” post-division state is no longer tied to expression of Ki67 and is instead a free parameter. We estimated the transition rate from fast to slow to be quite low, such that the average time spent in the bursting state is determined instead by the cell life span, which was 4 to 5 days. Consequently, the efficiency of return to quiescence from the burst phase was rather low, with only approximately 1% of cells surviving the transition. We found a comparably low efficiency of survival from fast to slow in the linear model. With this additional flexibility, the burst model yielded essentially identical fits to the branched and linear models. We also found that all three models yielded similar predictions for the outcome of the experiment that followed the behaviour of cohorts of cells enriched for fast or slow cells (Fig 7). Therefore, the kinetic substructures of CD4 TCM and TEM remain unclear. We speculate they may only be decipherable with single-cell approaches such as barcoding.

Our analyses gave clues as to the sources of new CD4 TCM and TEM. By comparing the donor cell content of the constant flow of new cells into the CD4 TCM and TEM pools to the donor content of other cell subsets, we saw clear evidence for a flux from TCM to TEM, likely from the rapidly dividing TCM population. We also found evidence that newly produced TCM derive largely from the naive CD4 T cell population in bulk. This was perhaps surprising; among mice housed in clean conditions, without overt infections, we expect naive T cells with appropriate TCR specificities for self or commensal antigens will be recruited into memory efficiently. In that case, one might expect recent thymic emigrants to be the dominant source of new memory, and so for this influx to be highly enriched for donor T cells. Instead, we saw continued recruitment of host cells into memory long after BMT, suggesting that even within SPF housing conditions, mice are regularly exposed to new antigenic stimuli. Alternatively, there may be a stochastic component to recruitment, such that naive T cells of any age have the potential to be stimulated to acquire a memory phenotype. Support for the latter idea comes from studies that implicate self antigens as important drivers of conversion to memory [12,18], and that proliferation is greatest among CD5hi cells [12], a marker whose expression correlates with TCR avidity for self. Conversion to memory is therefore likely be an inefficient process since we would expect the naive precursors to be relatively low affinity for self-antigens; the majority of T cells with high affinity for self are deleted in the thymus. The efficiency of recruitment could also be subject to repression by regulatory T cells. Further, as mentioned above, within these relatively low affinity memory populations, any dependence of survival on affinity for self may lead to selection for fitter clones with cell age and may explain the increase in the average clonal life expectancy over time. The preferential retention of such clones may then be relevant to understanding the increasing incidence of autoimmune disease that occurs with old age. These ideas need to be tested in future studies.

Material and methods

Generation of busulfan chimeric mice

Busulfan chimeric C57Bl6/J mice were generated as described in [24]. In summary, WT CD45.1 and CD45.2 mice were bred and maintained in conventional pathogen-free colonies at the Royal Free Campus of University College London. CD45.1 mice aged 8 weeks were treated with 20 mg/kg busulfan (Busilvex, Pierre Fabre) to deplete HSC and reconstituted with T cell–depleted bone marrow cells from congenic donor WT CD45.2 mice. Chimeras were killed weeks after bone marrow transplantation. Cervical, brachial, axillary, inguinal, and mesenteric lymph nodes were dissected from mice; single-cell suspensions prepared and analysed by flow cytometry. BrdU (Sigma) was administered to busulfan chimeric mice by an initial intraperitoneal injection of 0.8 mg BrdU, followed by maintenance of 0.8 mg/mL BrdU in drinking water for the indicated time periods up to 21 days. BrdU in drinking water was refreshed every 2 to 3 days. All experiments were performed in accordance with UK Home Office regulations, project license number PP2330953.

Reporter mouse strains

Ki67mCheery-CreERT reporter mice (Mki67tm1.1(cre/ERT2)Bsed) have been described previously [26]. These mice were crossed with a Cre reporter strain in which a CAG promoter driven YFP is expressed from the Rosa26 locus following Cre mediated excision of upstream transcriptional stop sequences; B6.Cg-Gt(ROSA)26Sortm3(CAG- EYFP)Hze/J (Jax strain 007903). Ki67mCherry-CreERT Rosa26RcagYFP mice were homozygous for the indicated mutations at both loci. CD4CreERT Rosa26RmTom reporter mice were generated by breeding Cd4CreERT2 mice [47] with B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J mice (Jax strain 7909). Experimental mice were heterozygous for the indicated mutations at both loci. Mice were treated with tamoxifen by a single intraperitoneal injection with 2 mg of tamxoxifen (Sigma) diluted in corn oil (Fisher Scientific).

Flow cytometry

Cells were stained with the following monoclonal antibodies and cell dyes: CD45.1 FITC, CD45.2 AlexaFluor 700, TCR-beta APC, CD4 PerCP-eFluor710, CD25 PE, CD44 APC-eFluor780, CD25 eFluor450, CD62L eFluor450 (all eBioscience), TCR-beta PerCP-Cy5.5, CD5 BV510, CD4 BV650, CD44 BV785 (all BioLegend), CD62L BUV737 (BD Biosciences), LIVE/DEAD nearIR and LIVE/DEAD Blue viability dyes (Invitrogen). BrdU and Ki67 costaining was performed using the FITC BrdU Flow Kit (BD Biosciences) according to the manufacturer’s instructions, along with anti-Ki67 eFluor660 (eBioscience). Cells were acquired on a BD LSR-II or BD LSR-Fortessa flow cytometer and analysed using Flowjo software (Treestar). Subset gates were as follows: CD4 naive: live TCRβ+ CD5+ CD4+ CD25 CD44 CD62L+. CD4 TEM: live TCRβ+ CD5+ CD4+ CD25 CD44+ CD62L. CD4 TCM: live TCRβ+ CD5+ CD4+ CD25 CD44+ CD62L+.

Cell transfers

For adoptive transfers, donor Ki67mCherry-CreERT Rosa26RcagYFP mice were injected with a single dose of tamoxifen, and three days later, total lymph nodes were isolated and CD4 T cells enriched using EasySep Mouse CD4+ T cell isolation kit. Cells were then labelled for CD25, CD4, TCR, CD62L, and CD44, and total CD4+ conventional or CD4 EM further purified by cell sorting on a BD FACS Aria Fusion. Cells (106/mouse) were transferred by tail vein injection into CD45.1 WT hosts. Seven days later, hosts were culled and donor cell phenotype in host lymph nodes analysed by flow.

Mathematical modelling and statistical analysis

The mathematical models and our approach to model fitting are detailed in Text A and Text B of S1 File, respectively. All code and data used to perform model fitting, and details of the prior distributions for parameters, are available at https://github.com/elisebullock/PLOS2024 and also at doi: 10.5281/zenodo.11476381. Models were ranked using the Leave-One-Out (LOO) cross validation method [48]. We quantified the relative support for models with the expected log pointwise predictive density (ELPD), for which we report the point estimate with standard error. Models with ELPD differences below 4 were considered indistinguishable.

Supporting information

S1 File. All supporting figures, tables, and text.

(PDF)

pbio.3002380.s001.pdf (4.4MB, pdf)
S1 Data. The data underlying the figures throughout the text and Supporting information.

(XLSX)

pbio.3002380.s002.xlsx (17.9MB, xlsx)

Abbreviations

BMT

bone marrow transplant

BrdU

bromodeoxyuridine

ELPD

expected log pointwise predictive density

HSC

haematopoietic stem cell

LOO

Leave-One-Out

MP

memory phenotype

RTE

recent thymic emigrant

TCR

T cell receptor

WT

wild-type

YFV

yellow fever virus

Data Availability

The mathematical models and our approach to model fitting are detailed in Text A and Text B of S1 File, respectively. All code and data used to perform model fitting, and details of the prior distributions for parameters, are available at https://github.com/elisebullock/PLOS2024 and also at doi:10.5281/zenodo.11476381.

Funding Statement

This study was funded by the National Institutes of Health (R01 AI093870 and U01 AI150680 to AJY) and the Medical Research Council (MR/P011225/1 to BS). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Swain SL, Agrewala JN, Brown DM, Jelley-Gibbs DM, Golech S, Huston G, et al. CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza. Immunol Rev. 2006;211(1):8–22. doi: 10.1111/j.0105-2896.2006.00388.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Tubo NJ, Jenkins MK. CD4+ T Cells: guardians of the phagosome. Clin Microbiol Rev. 2014;27(2):200–213. doi: 10.1128/CMR.00097-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Künzli M, Masopust D. CD4+ T cell memory. Nat Immunol. 2023;16:4. doi: 10.1038/s41590-023-01510-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Westera L, Drylewicz J, den Braber I, Mugwagwa T, van der Maas I, Kwast L, et al. Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans. Blood. 2013;122(13):2205–2212. doi: 10.1182/blood-2013-03-488411 [DOI] [PubMed] [Google Scholar]
  • 5.Gossel G, Hogan T, Cownden D, Seddon B, Yates AJ. Memory CD4 T cell subsets are kinetically heterogeneous and replenished from naive T cells at high levels. Elife 2017;6:e23013. doi: 10.7554/eLife.23013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Baliu-Piqué M, Verheij MW, Drylewicz J, Ravesloot L, de Boer RJ, Koets A, et al. Short Lifespans of Memory T-cells in Bone Marrow, Blood, and Lymph Nodes Suggest That T-cell Memory Is Maintained by Continuous Self-Renewal of Recirculating Cells. Front Immunol. 2018;9:2054. doi: 10.3389/fimmu.2018.02054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Borghans JAM, Tesselaar K, de Boer RJ. Current best estimates for the average lifespans of mouse and human leukocytes: reviewing two decades of deuterium-labeling experiments. Immunol Rev. 2018;285(1):233–248. doi: 10.1111/imr.12693 [DOI] [PubMed] [Google Scholar]
  • 8.Baliu-Piqué M, Otto SA, Borghans JAM, Tesselaar K. In vivo deuterium labelling in mice supports a dynamic model for memory T-cell maintenance in the bone marrow. Immunol Lett. 2019;210:29–32. doi: 10.1016/j.imlet.2019.04.004 [DOI] [PubMed] [Google Scholar]
  • 9.Derksen LY, Tesselaar K, Borghans JAM. Memories that last: Dynamics of memory T cells throughout the body. Immunol Rev. 2023;316(1):38–51. doi: 10.1111/imr.13211 [DOI] [PubMed] [Google Scholar]
  • 10.del Amo PC, Beneytez JL, Boelen L, Ahmed R, Miners KL, Zhang Y, et al. Human TSCM cell dynamics in vivo are compatible with long-lived immunological memory and stemness. PLoS Biol. 2018;16(6):1–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jameson SC, Lee YJ, Hogquist KA. Innate Memory T cells. Adv Immunol. 2015;126:173–213. doi: 10.1016/bs.ai.2014.12.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kawabe T, Jankovic D, Kawabe S, Huang Y, Lee PHH, Yamane H, et al. Memory-phenotype CD4+ T cells spontaneously generated under steady state conditions exert innate Th1-like effector function. Sci Immunol. 2017;2(12):16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Min B, Paul WE. Endogenous proliferation: burst-like CD4 T cell proliferation in lymphopenic settings. Semin Immunol. 2005;17(3):201–207. doi: 10.1016/j.smim.2005.02.005 [DOI] [PubMed] [Google Scholar]
  • 14.Tough DF, Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med. 1994;179(4):1127–1135. doi: 10.1084/jem.179.4.1127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lenz DC, Kurz SK, Lemmens E, Schoenberger SP, Sprent J, Oldstone MB, et al. IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. Proc Natl Acad Sci U S A. 2004;101(25):9357–9362. doi: 10.1073/pnas.0400640101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Purton JF, Tan JT, Rubinstein MP, Kim DM, Sprent J, Surh CD. Antiviral CD4+ memory T cells are IL-15 dependent. J Exp Med. 2007;204(4):951–961. doi: 10.1084/jem.20061805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Younes SA, Punkosdy G, Caucheteux S, Chen T, Grossman Z, Paul WE. Memory phenotype CD4 T cells undergoing rapid, nonburst-like, cytokine-driven proliferation can be distinguished from antigen-experienced memory cells. PLoS Biol. 2011;9(10):e1001171. doi: 10.1371/journal.pbio.1001171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hogan T, Nowicka M, Cownden D, Pearson CF, Yates AJ, Seddon B. Differential impact of self and environmental antigens on the ontogeny and maintenance of CD4+ T cell memory. Elife. 2019:8. doi: 10.7554/eLife.48901 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mohri H, Perelson AS, Tung K, Ribeiro RM, Ramratnam B, Markowitz M, et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med. 2001;194(9):1277–1287. doi: 10.1084/jem.194.9.1277 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Asquith B, Debacq C, Macallan DC, Willems L, Bangham CRM. Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol. 2002;23(12):596–601. doi: 10.1016/s1471-4906(02)02337-2 [DOI] [PubMed] [Google Scholar]
  • 21.Ganusov VV, Borghans JAM, De Boer RJ. Explicit kinetic heterogeneity: mathematical models for interpretation of deuterium labeling of heterogeneous cell populations. PLoS Comput Biol. 2010;6(2):e1000666. doi: 10.1371/journal.pcbi.1000666 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.De Boer RJ, Perelson AS, Ribeiro RM. Modelling deuterium labelling of lymphocytes with temporal and/or kinetic heterogeneity. J R Soc Interface. 2012;9(74):2191–2200. doi: 10.1098/rsif.2012.0149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hogan T, Gossel G, Yates AJ, Seddon B. Temporal fate mapping reveals age-linked heterogeneity in naive T lymphocytes in mice. Proc Natl Acad Sci. 2015;112(50):E6917–E6926. doi: 10.1073/pnas.1517246112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hogan T, Yates A, Seddon B. Generation of Busulfan chimeric mice for the analysis of T cell population dynamics. Bioanalysis. 2017;4(24). doi: 10.21769/BioProtoc.2650 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hogan T, Yates A, Seddon B. Analysing temporal dynamics of T cell division in vivo using Ki67 and BrdU co-labelling by flow cytometry. Bio Protoc. 2017;7(24). doi: 10.21769/BioProtoc.2649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Verheijen M, Rane S, Pearson C, Yates AJ, Seddon B. Fate Mapping Quantifies the Dynamics of B Cell Development and Activation throughout Life. Cell Rep. 2020;33(7):108376. doi: 10.1016/j.celrep.2020.108376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Rane S, Hogan T, Seddon B, Yates AJ. Age is not just a number: Naive T cells increase their ability to persist in the circulation over time. PLoS Biol. 2018;16(4):e2003949. doi: 10.1371/journal.pbio.2003949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rane S, Hogan T, Lee E, Seddon B, Yates AJ. Towards a unified model of naive T cell dynamics across the lifespan. Elife. 2022;11:11. doi: 10.7554/eLife.78168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lukas E, Hogan T, Williams C, Seddon B, Yates AJ. Quantifying cellular dynamics in mice using a novel fluorescent division reporter system. Front Immunol. 2023:14. doi: 10.3389/fimmu.2023.1157705 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sasaki K, Murakami T, Kawasaki M, Takahashi M. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol. 1987;133(3):579–584. doi: 10.1002/jcp.1041330321 [DOI] [PubMed] [Google Scholar]
  • 31.Miller I, Min M, Yang C, Tian C, Gookin S, Carter D, et al. Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell Rep. 2018;24(5):1105–1112.e5. doi: 10.1016/j.celrep.2018.06.110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.De Boer RJ, Yates AJ. Modeling T Cell Fate. Annu Rev Immunol. 2023;41:513–532. doi: 10.1146/annurev-immunol-101721-040924 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Costa Del Amo P, Debebe B, Razavi-Mohseni M, Nakaoka S, Worth A, Wallace D, et al. The Rules of Human T Cell Fate in vivo. Front Immunol. 2020;11:573. doi: 10.3389/fimmu.2020.00573 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.De Boer RJ, Perelson AS. Quantifying T lymphocyte turnover. J Theor Biol. 2013;327:45–87. doi: 10.1016/j.jtbi.2012.12.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Schittler D, Allgöwer F, De Boer RJ. A new model to simulate and analyze proliferating cell populations in BrdU labeling experiments. BMC Syst Biol. 2013;7(Suppl 1):S4. doi: 10.1186/1752-0509-7-S1-S4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tsukamoto H, Clise-Dwyer K, Huston GE, Duso DK, Buck AL, Johnson LL, et al. Age-associated increase in lifespan of naive CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects. Proc Natl Acad Sci U S A. 2009;106(43):18333–18338. doi: 10.1073/pnas.0910139106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mold JE, Réu P, Olin A, Bernard S, Michaëlsson J, Rane S, et al. Cell generation dynamics underlying naive T-cell homeostasis in adult humans. PLoS Biol. 2019;17(10). doi: 10.1371/journal.pbio.3000383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Swain AC, Borghans JAM, de Boer RJ. Effect of cellular aging on memory T-cell homeostasis. Front Immunol. 2022;13:947242. doi: 10.3389/fimmu.2022.947242 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Linton PJ, Haynes L, Tsui L, Zhang X, Swain S. From naive to effector–alterations with aging. Immunol Rev. 1997;160:9–18. doi: 10.1111/j.1600-065x.1997.tb01023.x [DOI] [PubMed] [Google Scholar]
  • 40.Haynes L, Linton PJ, Eaton SM, Tonkonogy SL, Swain SL. Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med. 1999;190(7):1013–1024. doi: 10.1084/jem.190.7.1013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Haynes L, Eaton SM, Burns EM, Rincon M, Swain SL. Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. J Immunol. 2004;172(9):5194–5199. doi: 10.4049/jimmunol.172.9.5194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Akondy RS, Fitch M, Edupuganti S, Yang S, Kissick HT, Li KW, et al. Origin and differentiation of human memory CD8 T cells after vaccination. Nature. 2017;552(7685):362–367. doi: 10.1038/nature24633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Zarnitsyna VI, Akondy RS, Ahmed H, McGuire DJ, Zarnitsyn VG, Moore M, et al. Dynamics and turnover of memory CD8 T cell responses following yellow fever vaccination. PLoS Comput Biol. 2021;17(10):e1009468. doi: 10.1371/journal.pcbi.1009468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol. 2003;4(7):680–686. doi: 10.1038/ni946 [DOI] [PubMed] [Google Scholar]
  • 45.Choo DK, Murali-Krishna K, Anita R, Ahmed R. Homeostatic turnover of virus-specific memory CD8 T cells occurs stochastically and is independent of CD4 T cell help. J Immunol. 2010;185(6):3436–3444. doi: 10.4049/jimmunol.1001421 [DOI] [PubMed] [Google Scholar]
  • 46.Pepper M, Linehan JL, Pagán AJ, Zell T, Dileepan T, Cleary PP, et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol. 2010;11(1):83–89. doi: 10.1038/ni.1826 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sledzińska A, Hemmers S, Mair F, Gorka O, Ruland J, Fairbairn L, et al. TGF-β signalling is required for CD4+ T cell homeostasis but dispensable for regulatory T cell function. PLoS Biol. 2013;11(10):e1001674. doi: 10.1371/journal.pbio.1001674 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Vehtari A, Gelman A, Gabry J. Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC. Stat Comput. 2017;27(5):1413–1432. doi: 10.1007/s11222-016-9696-4 [DOI] [Google Scholar]

Decision Letter 0

Paula Jauregui, PhD

15 Oct 2023

Dear Dr. Yates,

Thank you for submitting your manuscript entitled "Cell age, but not chronological age, governs the dynamics and longevity of circulating CD4 + memory T cells" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff and I am writing to let you know that we would like to send your submission out for external peer review as an Update Article. Please select this option in the system when re-submitting.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Oct 17 2023 11:59PM.

If your manuscript has been previously peer-reviewed at another journal, PLOS Biology is willing to work with those reviews in order to avoid re-starting the process. Submission of the previous reviews is entirely optional and our ability to use them effectively will depend on the willingness of the previous journal to confirm the content of the reports and share the reviewer identities. Please note that we reserve the right to invite additional reviewers if we consider that additional/independent reviewers are needed, although we aim to avoid this as far as possible. In our experience, working with previous reviews does save time.

If you would like us to consider previous reviewer reports, please edit your cover letter to let us know and include the name of the journal where the work was previously considered and the manuscript ID it was given. In addition, please upload a response to the reviews as a 'Prior Peer Review' file type, which should include the reports in full and a point-by-point reply detailing how you have or plan to address the reviewers' concerns.

During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Paula

---

Paula Jauregui, PhD,

Senior Editor

PLOS Biology

pjaureguionieva@plos.org

Decision Letter 1

Ines Alvarez-Garcia

20 Dec 2023

Dear Dr Yates,

Thank you for your patience while your manuscript entitled "Cell age, not chronological age, governs the dynamics and longevity of circulating CD4+ memory T cells" was peer-reviewed at PLOS Biology as an Update Article. Please also accept my sincere apologies for the delay in providing you with our decision. The manuscript has now been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by three independent reviewers.

As you will see, the reviewers find the conclusions interesting, but they also raise several issues that would need to be addressed before we can consider the manuscript for publication. Reviewer 1 has concerns about the model on whether you are comparing different processes between host and donor cells – older host cells with younger donor cells, rather that memory with naïve T cells – and also regarding the cell-age effects vs cell environment. In addition, this reviewer thinks you should discuss better the likely composition of the cells referred as ‘memory’ cells, among other issues. Reviewer 2 asks for additional analyses, including checking if CD4 and CD8 memory cells show a similar behaviour and several clarifications. Reviewer 3 thinks that the limitations should be expressed more clearly, so we suggest adding a section on limitations of the study to the discussion to address this point.

In light of the reviews, we would like to invite you to revise the work to thoroughly address the reviewers' reports. Given the extent of revision needed, we cannot make a decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is likely to be sent for further evaluation by all or a subset of the reviewers.

We expect to receive your revised manuscript within 3 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension.

At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may withdraw it.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point-by-point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted" file type.

3. Resubmission Checklist

When you are ready to resubmit your revised manuscript, please refer to this resubmission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision and fulfil the editorial requests:

a) *PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). Please also indicate in each figure legend where the data can be found. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

b) *Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

c) *Blot and Gel Data Policy*

Please provide the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

d) *Blurb*

Please also provide a blurb which (if accepted) will be included in our weekly and monthly Electronic Table of Contents, sent out to readers of PLOS Biology, and may be used to promote your article in social media. The blurb should be about 30-40 words long and is subject to editorial changes. It should, without exaggeration, entice people to read your manuscript. It should not be redundant with the title and should not contain acronyms or abbreviations. For examples, view our author guidelines: https://journals.plos.org/plosbiology/s/revising-your-manuscript#loc-blurb

e) *Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

----------------------------------------

Reviewers' comments

Rev. 1:

In this article, Bullock et al have combined wet lab experiments with mathematical modelling to examine memory phenotype CD4 T cells in mice. The field struggles to classify these cells that likely are composed of different populations that have responded following stimulation with cytokines and/or antigens, and in some cases are specific for antigens which are presented for short periods of time or specific for antigens which persist. The authors dissect the population of memory CD4 T cells in various ways - first by whether they express the lymph node homing molecule, CD62L and are classified by the field as Tcentral memory (CD62L+) or Teffector memory (CD62Llo/negative). Second, by whether they express a congenic molecule that marks them as host derived, or derived from a transfer of bone marrow stem cells when the hosts are around 50-100 days old. The authors also follow on from previous findings in the field describing that some memory phenotype CD4 T cells proliferate frequency and some very infrequently and there is not currently a consensus on an underlying mechanism to explain these different behaviours.

The authors' aims were to understand the proliferation of the CD4 T cells within these populations, predict life spans, and investigate the relationship between the memory populations.

The main findings described in the manuscript are:

1. Fast and slow dividing memory CD4 T cells can be found in both Tcm and Tem populations and in young and older mice.

2. But memory cells are more likely to divide in younger than older mice and at both time points, the donor cells are more likely to divide than the original host memory cells.

3. The differences in proliferation kinetics are less pronounced in the older mice than the younger mice.

4. The formation of Tem and Tcm cells can be explained by two different models in which Tcm and Tem are separate populations (branching) or in which Tcm convert into Tem (linear).

5. The life span of memory cell populations is similar to previous calculated values from other investigators.

The authors use these findings to conclude that cell age, rather than host environment, predict the proliferate behaviour of memory phenotype CD4 T cells. These data are potentially important as the longevity of memory CD4 T cells is key to understanding protective immunity to pathogens that the host as met previously through infection or vaccination. Long lived populations of CD4 T cells are more likely to provide durable immunity than short lived cells.

Overall, this is a well-written manuscript that combines the strengths of the authors in wet lab studies and mathematical modelling. I am a wet lab biologists and have limited ability to review the veracity of the modelling aspects of the manuscript.

The main strengths are that the authors have generated a substantial data set that allows for analysis of populations of memory CD4 T cells across time and which can probe the proliferation dynamics of the cells and generated different models to test hypotheses about the relationships between the cells.

The main weaknesses are that the authors have made a number of assumptions as they moved from findings to conclusions (see points 1 and 2 below) and that much of the work confirms previous findings (lifespan of memory populations) rather than presenting novel conclusions or hypotheses (i.e. differentiation of naïve cells into memory cells that may/may not require cells to go through a Tcm before a Tem phenotype).

Main concerns:

1. Are the authors modelling different processes between host and donor cells?

The diagram in Fig1A suggests that naïve CD4 T cells are predominantly donor derived at the analysis time point; the data in Fig2D suggests that donor derived memory phenotype cells are more likely to be Ki67+ than host memory cells. Is the explanation for the latter that the cells are coming from the naïve population? The authors investigate this later in the manuscript and conclude that, at least the Tcm population, is likely derived from the naïve CD4 T cell pool. They state in the discussion (line 419) that there is 'substantial recruitment of host cells into memory' and imply these are coming from the naïve pool. It wasn't clear to me what data this referred to and how the author ruled out that the host proliferating memory cells were memory cells re-activated by antigen and/or cytokine while the donor cells where newly activated naïve cells entering the activated/memory pool for the first time.

Thus, it is not clear to me how the authors can argue that they are comparing 'older' host cells with 'younger' donor cells rather than 'memory' with 'naïve' T cells. If they can't make this distinction, their main conclusion about the distinctions in proliferative behaviour between young and old cells is not supported. In the older cohort of mice, the differences between the host and donor cells is much less - this may be because here they are mainly comparing memory host cells with memory donor cells.

2. Argument that 'cell-age' effects dominate over the cell's environment.

This follows on from the concern above but contains a further distinction that the authors have not considered. This is that while the donor and host CD4 T cells are within the same host, they may be found in distinct microenvironments in the secondary lymphoid organs, and thus exposed to different levels of cytokines, different types of antigen presenting cells, and thus more or less likely to be exposed to antigen.

3. Lifespans - the authors describe half-lives (35-140 days) and mean lifespan (18-20 days). Can they explain the different measurements?

4. The authors have limited discussion on the cells that included/excluded from the populations. They have excluded CD25+ cells and thus will be excluding some, but not all of the Tregs. While CD25 exclusion will also mean they are excluding recently activated T cells from the analysis, CD25 is very transient on activated cells and thus their 'memory' populations are likely to include 'activated' cells. The authors themselves state that memory phenotype cells are derived from naïve cells and that some of these may be responding to environmental antigens even without overt infection/vaccination. It would be helpful if the authors include a few statements to describe the likely composition of the cells they refer to as 'memory' cells.

Minor concerns:

1. In the abstract, the author refer to clones - they have examined populations of cells not individual clones so this language is perhaps not appropriate.

2. It would be useful if the authors provide example gating for the T cells analysed, e.g. in a supplemental figure. It is also now standard to include the fluorochrome used in the axis label of the flow plot e.g. in Fig 1C and to include the axes numbers.

3. In Figure 1 part C Ki67/BrdU panels, it is unclear if the cells displayed are all T cells or the CD45.1 or CD45.2 cells. The legend suggests that are 'stratified' by donor/host but it wasn't clear which (or both) are shown.

4. In the methods, the authors should state the age of the mice used for the donor bone marrow, are these the same age as the host animals? This is important and HSC can show effects of age.

5. In Fig3C, CD4 Tcm proportion graph, it looks like there is only one blue/donor point at day 15. I am guessing there two points are on top of each other? Can they nudge one point slightly to enable the reader to see both points.

6. In the legend of Fig 3, it would be helpful to state that the lines show the predicted curves for the branched model, this is my understanding from the text in the paragraph with lines number 185-194.

7. Unclear what the word 'cohoxhich' means on line 295. Perhaps meant to say 'cohort in which'?

8. Extra 'was' in line 390.

9. The methods should contain information on which lymph nodes were examined and how the lymph nodes were processed and counted.

10. The methods should state how the busulfan was given to the mice, how many donor cells were transferred, how the donor cells were transferred and how the bone marrow was prepared (especially how depleted of B and T cells). Alternatively, If a prior publication contains detailed methods, this could be referenced in the methods section.

In terms of scope for an 'Update Article' my understanding is that the manuscript follows on from Rane et al, PLOS Biology, 2018. The 2018 paper examines survival of naïve CD4 T cells while the new manuscript examines memory CD4 T cells. The two studies thus ask similar questions of distinct populations using some similar methods. Thus, the two studies are certainly related but the results do go beyond the findings in the 2018 paper.

Rev. 2: Jose Borghans – note that this reviewer has signed his review

This paper elegantly tears apart the effects of the age of the host versus the age of the cell on the dynamics of circulating memory CD4+ T cells, and thereby gives important insights into the long-term maintenance of immunological memory. Generally speaking, the manuscript is clearly written, makes an important contribution to the field of immunological memory, is based on robust analyses, and in my opinion fits the scope of PLoS Biology.

I have a few questions and suggestions:

- I was wondering why the authors "only" report results for CD4 memory T cells. I would assume one could obtain information from both CD4 and CD8 memory T cells

Decision Letter 2

Ines Alvarez-Garcia

28 Mar 2024

Dear Dr Yates,

Thank you for your patience while we considered your revised manuscript "Cell age, not chronological age, governs the dynamics and longevity of circulating CD4+ memory T cells" for publication as a Update Article at PLOS Biology. This revised version of your manuscript has been evaluated by the PLOS Biology editors, the Academic Editor and the original reviewers.

Based on the reviews and on our Academic Editor's assessment of your revision, we are likely to accept this manuscript for publication, provided you satisfactorily address the remaining points raised by the reviewers. Please also make sure to address the following data and other policy-related requests.

* We would like to suggest a different title to improve readability: "The dynamics and longevity of circulating CD4+ memory T cells depend on the age of the cells and not the chronological age of the host"

* Please add the links to the funding agencies in the Financial Disclosure statement in the manuscript details.

DATA POLICY:

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it: 2A–D, 4A, 4B, 5A–C, 6, and 7B.

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

------------------------------------------------------------------------

CODE POLICY

Per journal policy, if you have generated any custom code during the curse of this investigation, please make it available without restrictions upon publication. Please ensure that the code is sufficiently well documented and reusable, and that your Data Statement in the Editorial Manager submission system accurately describes where your code can be found.

Please note that we cannot accept sole deposition of code in GitHub, as this could be changed after publication. However, you can archive this version of your publicly available GitHub code to Zenodo. Once you do this, it will generate a DOI number, which you will need to provide in the Data Accessibility Statement (you are welcome to also provide the GitHub access information). See the process for doing this here: https://docs.github.com/en/repositories/archiving-a-github-repository/referencing-and-citing-content

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list

- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable, if not applicable please do not delete your existing 'Response to Reviewers' file.)

- a track-changes file indicating any changes that you have made to the manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*Press*

Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Sincerely,

Christian

Christian Schnell (on behalf of Ines who is out of office this week)

Senior Editor

cschnell@plos.org

PLOS Biology

Ines Alvarez-Garcia, PhD

Senior Editor

ialvarez-garcia@plos.org

PLOS Biology

Reviewer remarks:

Reviewer #1: Thank you to the authors for responding to the questions and concerns in the first review.

The revised manuscript explains the results and caveats of the approaches and describes the authors' findings in the context of the literature.

I do have two concerns on the new text/material

1. Line 254, 'measures the persistence of a TCR clonotype'. This text implies the author have tracked the CD4 T cell populations by TCR clonotype, can they re-phrase the text? The main concern here is potential confusion by readers, especially as the detailed methods used in these studies must be read in a different paper.

2. The experiments shown in the Figure 7: my understanding is that these are new experiments that have not been previously described in the 2017 Bio-protocol paper. It is important, therefore, that more complete methodology and some relevant flow plots/gating are included in this manuscript to allow readers to evaluate the method and primary data. The new data are consistent with the authors' conclusions based on the busulfan chimeras but the current limited experimental detail, especially for the transfer experiment (Fig 7A-B), mean that alternative explanations of these results are possible.

In particular, how the Tem and bulk CD4 T cells were isolated (e.g. by magnetic sorting or FACS-based sorting?) should be described. If different methods were used to sort the Tem and bulk CD4 T cells, this could be an alternative, technical explanation for the difference in proliferation described in Fig 7. Similarly, were equal number of bulk and Tem cells transferred, or the same number of Tem transferred in each population? Without these data and inclusion of some ex vivo day 7 flow plots, the reader cannot know how reliable the %Ki67-mCherry data are. Same argument for the mTomato+ cell populations.

Additionally, it is unclear if the day 0 time point in Fig 7B shows data for the cells pre-transfer of are transferred cells examined on the same day of transfer to take account for the loss of cells following the transfer. Some additional clarity on these experiments is required.

Reviewer #2 (Jose Borghans): I'm happy with the way the authors addressed my points and would recommend publication of the paper.

Decision Letter 3

Ines Alvarez-Garcia

24 Jun 2024

Dear Dr Yates,

Thank you for the submission of your revised Research Article entitled "The dynamics and longevity of circulating CD4+ memory T cells depend on cell age and not the chronological age of the host" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, Avinash Bhandoola, I am delighted to let you know that we can in principle accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Many congratulations and thanks again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. 

Sincerely, 

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. All supporting figures, tables, and text.

    (PDF)

    pbio.3002380.s001.pdf (4.4MB, pdf)
    S1 Data. The data underlying the figures throughout the text and Supporting information.

    (XLSX)

    pbio.3002380.s002.xlsx (17.9MB, xlsx)
    Attachment

    Submitted filename: Bullock Plos Biology 2024 - Response 1.pdf

    pbio.3002380.s003.pdf (2.6MB, pdf)

    Data Availability Statement

    The mathematical models and our approach to model fitting are detailed in Text A and Text B of S1 File, respectively. All code and data used to perform model fitting, and details of the prior distributions for parameters, are available at https://github.com/elisebullock/PLOS2024 and also at doi:10.5281/zenodo.11476381.


    Articles from PLOS Biology are provided here courtesy of PLOS

    RESOURCES